Park Avenue Securities’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.1M | Sell |
27,835
-202
| -0.7% | -$69.1K | 0.06% | 237 |
|
|
2026
Q1 | $9.87M | Sell |
28,037
-2,968
| -10% | -$1.06M | 0.08% | 198 |
|
|
2025
Q4 | $10.1M | Buy |
31,005
+536
| +2% | +$170K | 0.09% | 185 |
|
|
2025
Q3 | $8.6M | Sell |
30,469
-597
| -2% | -$173K | 0.07% | 217 |
|
|
2025
Q2 | $8.67M | Sell |
31,066
-7,998
| -20% | -$2.27M | 0.08% | 184 |
|
|
2025
Q1 | $12.2M | Buy |
39,064
+4,320
| +12% | +$1.28M | 0.15% | 90 |
|
|
2024
Q4 | $9.06M | Buy |
34,744
+3,340
| +11% | +$991K | 0.09% | 149 |
|
|
2024
Q3 | $10.1M | Sell |
31,404
-3,767
| -11% | -$1.23M | 0.11% | 124 |
|
|
2024
Q2 | $11M | Buy |
35,171
+3,521
| +11% | +$1.03M | 0.13% | 111 |
|
|
2024
Q1 | $9M | Buy |
31,650
+353
| +1% | +$103K | 0.12% | 128 |
|
|
2023
Q4 | $9.01M | Buy |
31,297
+1,759
| +6% | +$479K | 0.12% | 109 |
|
|
2023
Q3 | $7.94M | Buy |
29,538
+4,660
| +19% | +$1.16M | 0.12% | 109 |
|
|
2023
Q2 | $5.52M | Sell |
24,878
-227
| -0.9% | -$52.7K | 0.09% | 151 |
|
|
2023
Q1 | $6.07M | Buy |
25,105
+998
| +4% | +$245K | 0.1% | 126 |
|
|
2022
Q4 | $6.33M | Buy |
24,107
+1,366
| +6% | +$366K | 0.11% | 114 |
|
|
2022
Q3 | $5.13M | Buy |
22,741
+1,838
| +9% | +$446K | 0.1% | 123 |
|
|
2022
Q2 | $5.09M | Buy |
20,903
+1,328
| +7% | +$325K | 0.1% | 126 |
|
|
2022
Q1 | $4.73M | Buy |
19,575
+12,437
| +174% | +$2.86M | 0.08% | 132 |
|
|
2021
Q4 | $1.61M | Buy |
7,138
+281
| +4% | +$59.3K | 0.03% | 320 |
|
|
2021
Q3 | $1.46M | Buy |
6,857
+114
| +2% | +$26.2K | 0.03% | 300 |
|
|
2021
Q2 | $1.64M | Buy |
6,743
+381
| +6% | +$93.7K | 0.03% | 261 |
|
|
2021
Q1 | $1.58M | Buy |
6,362
+135
| +2% | +$32.2K | 0.04% | 239 |
|
|
2020
Q4 | $1.43M | Sell |
6,227
-78
| -1% | -$18K | 0.04% | 206 |
|
|
2020
Q3 | $1.6M | Buy |
6,305
+239
| +4% | +$59.2K | 0.05% | 153 |
|
|
2020
Q2 | $1.43M | Buy |
6,066
+290
| +5% | +$66.2K | 0.05% | 148 |
|
|
2020
Q1 | $1.17M | Buy |
5,776
+1,466
| +34% | +$320K | 0.1% | 76 |
|
|
2019
Q4 | $1.04M | Buy |
4,310
+1,244
| +41% | +$274K | 0.04% | 174 |
|
|
2019
Q3 | $593K | Sell |
3,066
-76
| -2% | -$14.6K | 0.03% | 221 |
|
|
2019
Q2 | $579K | Sell |
3,142
-4,063
| -56% | -$728K | 0.06% | 109 |
|
|
2019
Q1 | $1.38M | Buy |
+7,205
| New | +$1.38M | 0.08% | 95 |
|
|
2017
Q3 | – | Sell |
-1,398
| Closed | -$248K | – | 120 |
|
|
2017
Q2 | $248K | Buy |
+1,398
| New | +$227K | 0.03% | 167 |
|
Other funds holding AMGN
Park Avenue Securities's AMGN Position: Q2 2026 in Review
Park Avenue Securities reduced its Amgen (AMGN) stake by 0.72% in Q2 2026, selling an estimated $69.1K and leaving 27,835 shares worth $10.1M. The position accounts for 0.06% of the portfolio, ranked #237.
Park Avenue Securities first reported a position in AMGN in Q2 2017 and has held it in 31 quarters since. The position peaked at $12.2M in Q1 2025. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Park Avenue Securities held 27,835 shares of Amgen worth $10.1M as of Q2 2026.
- Park Avenue Securities sold 202 Amgen shares in Q2 2026, an estimated $69.1K.
- Amgen made up 0.06% of Park Avenue Securities's portfolio in Q2 2026, its #237 holding.
- Park Avenue Securities first reported a position in Amgen in Q2 2017 and has held it in 31 quarters since.
- Park Avenue Securities's Amgen position peaked at $12.2M in Q1 2025.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.